Literature DB >> 31792462

Plasma protein patterns as comprehensive indicators of health.

Stephen A Williams1, Peter Ganz2, Nicholas J Wareham3, Mika Kivimaki4, Claudia Langenberg3, Aroon D Hingorani5,6,7, J P Casas8, Claude Bouchard9, Christian Jonasson10, Mark A Sarzynski11, Martin J Shipley4, Leigh Alexander12, Jessica Ash12, Tim Bauer12, Jessica Chadwick12, Gargi Datta12, Robert Kirk DeLisle12, Yolanda Hagar12, Michael Hinterberg12, Rachel Ostroff12, Sophie Weiss12.   

Abstract

Proteins are effector molecules that mediate the functions of genes1,2 and modulate comorbidities3-10, behaviors and drug treatments11. They represent an enormous potential resource for personalized, systemic and data-driven diagnosis, prevention, monitoring and treatment. However, the concept of using plasma proteins for individualized health assessment across many health conditions simultaneously has not been tested. Here, we show that plasma protein expression patterns strongly encode for multiple different health states, future disease risks and lifestyle behaviors. We developed and validated protein-phenotype models for 11 different health indicators: liver fat, kidney filtration, percentage body fat, visceral fat mass, lean body mass, cardiopulmonary fitness, physical activity, alcohol consumption, cigarette smoking, diabetes risk and primary cardiovascular event risk. The analyses were prospectively planned, documented and executed at scale on archived samples and clinical data, with a total of ~85 million protein measurements in 16,894 participants. Our proof-of-concept study demonstrates that protein expression patterns reliably encode for many different health issues, and that large-scale protein scanning12-16 coupled with machine learning is viable for the development and future simultaneous delivery of multiple measures of health. We anticipate that, with further validation and the addition of more protein-phenotype models, this approach could enable a single-source, individualized so-called liquid health check.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31792462      PMCID: PMC6922049          DOI: 10.1038/s41591-019-0665-2

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  71 in total

1.  Inhibition of the Complement Alternative Pathway by Chemically Modified DNA Aptamers That Bind with Picomolar Affinity to Factor B.

Authors:  Xin Xu; Chi Zhang; Dalton T Denton; Daniel O'Connell; Daniel W Drolet; Brian V Geisbrecht
Journal:  J Immunol       Date:  2021-01-08       Impact factor: 5.422

2.  Bead-Based Assays for Validating Proteomic Profiles in Body Fluids.

Authors:  Annika Bendes; Matilda Dale; Cecilia Mattsson; Tea Dodig-Crnković; Maria Jesus Iglesias; Jochen M Schwenk; Claudia Fredolini
Journal:  Methods Mol Biol       Date:  2021

3.  Proteomics for personalized cardiovascular risk assessment: in pursuit of the Holy Grail.

Authors:  Peter Ganz; Rajat Deo; Ruth F Dubin
Journal:  Eur Heart J       Date:  2020-11-01       Impact factor: 29.983

Review 4.  Measuring biological age using omics data.

Authors:  Jarod Rutledge; Hamilton Oh; Tony Wyss-Coray
Journal:  Nat Rev Genet       Date:  2022-06-17       Impact factor: 53.242

5.  Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients.

Authors:  Richard X Liu; Heather R Thiessen-Philbrook; Ramachandran S Vasan; Josef Coresh; Peter Ganz; Joseph V Bonventre; Paul L Kimmel; Chirag R Parikh
Journal:  Transl Res       Date:  2021-07-31       Impact factor: 7.012

Review 6.  Systems biology in cardiovascular disease: a multiomics approach.

Authors:  Abhishek Joshi; Marieke Rienks; Konstantinos Theofilatos; Manuel Mayr
Journal:  Nat Rev Cardiol       Date:  2020-12-18       Impact factor: 32.419

7.  Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.

Authors:  Lasse Folkersen; Stefan Gustafsson; Qin Wang; Michael V Holmes; Erik Ingelsson; Anders Mälarstig; Daniel Hvidberg Hansen; Åsa K Hedman; Andrew Schork; Karen Page; Daria V Zhernakova; Yang Wu; James Peters; Niclas Eriksson; Sarah E Bergen; Thibaud S Boutin; Andrew D Bretherick; Stefan Enroth; Anette Kalnapenkis; Jesper R Gådin; Bianca E Suur; Yan Chen; Ljubica Matic; Jeremy D Gale; Julie Lee; Weidong Zhang; Amira Quazi; Mika Ala-Korpela; Seung Hoan Choi; Annique Claringbould; John Danesh; George Davey Smith; Federico de Masi; Sölve Elmståhl; Gunnar Engström; Eric Fauman; Celine Fernandez; Lude Franke; Paul W Franks; Vilmantas Giedraitis; Chris Haley; Anders Hamsten; Andres Ingason; Åsa Johansson; Peter K Joshi; Lars Lind; Cecilia M Lindgren; Steven Lubitz; Tom Palmer; Erin Macdonald-Dunlop; Martin Magnusson; Olle Melander; Karl Michaelsson; Andrew P Morris; Reedik Mägi; Michael W Nagle; Peter M Nilsson; Jan Nilsson; Marju Orho-Melander; Ozren Polasek; Bram Prins; Erik Pålsson; Ting Qi; Marketa Sjögren; Johan Sundström; Praveen Surendran; Urmo Võsa; Thomas Werge; Rasmus Wernersson; Harm-Jan Westra; Jian Yang; Alexandra Zhernakova; Johan Ärnlöv; Jingyuan Fu; J Gustav Smith; Tõnu Esko; Caroline Hayward; Ulf Gyllensten; Mikael Landen; Agneta Siegbahn; James F Wilson; Lars Wallentin; Adam S Butterworth
Journal:  Nat Metab       Date:  2020-10-16

8.  Plasma metabolites to profile pathways in noncommunicable disease multimorbidity.

Authors:  Maik Pietzner; Isobel D Stewart; Johannes Raffler; Kay-Tee Khaw; Gregory A Michelotti; Gabi Kastenmüller; Nicholas J Wareham; Claudia Langenberg
Journal:  Nat Med       Date:  2021-03-11       Impact factor: 53.440

9.  Circulating testican-2 is a podocyte-derived marker of kidney health.

Authors:  Debby Ngo; Donghai Wen; Yan Gao; Michelle J Keyes; Erika R Drury; Dan H Katz; Mark D Benson; Sumita Sinha; Dongxiao Shen; Laurie A Farrell; Bennet D Peterson; David J Friedman; Sammy Elmariah; Bessie A Young; J Gustav Smith; Qiong Yang; Ramachandran S Vasan; Martin G Larson; Adolfo Correa; Benjamin D Humphreys; Thomas J Wang; Martin R Pollak; James G Wilson; Robert E Gerszten; Eugene P Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

Review 10.  The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk.

Authors:  Matthew Nayor; Kemar J Brown; Ramachandran S Vasan
Journal:  Circ Res       Date:  2021-01-21       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.